先天性眼前节异常的商业基因检测组合:它们都一样吗?
该观察性研究比较了5家商业实验室针对先天性眼前节异常(CASA)的下一代测序多基因组合(NGS-MGP),涵盖白内障、青光眼、角膜营养不良、小眼球-无眼球-眼组织缺损(MAC)、眼前节发育不良(ASD)和Axenfeld-Rieger综合征(ARS)。结果显示各组合覆盖基因数量差异大,共识率16%-50%,独有率14%-74%,并发基因与疾病相关性更强。作者认为需严谨的前瞻性诊断率研究来指导组合选择。
要点
- 5家商业实验室的NGS-MGP在白内障、青光眼、角膜营养不良、MAC、ASD和ARS中分别检测239、60、36、292和10个离散基因。
- 各疾病组合的共识率(所有组合均覆盖的基因比例)为16%-50%,独有率(仅1个组合覆盖的基因比例)为14%-74%。
- 白内障和青光眼中,并发基因与疾病的相关性显著强于独有基因;作者认为需前瞻性诊断率研究指导组合选择。
核心结论
- 使用NGS-MGP对CASA进行基因检测因组合数量、种类及表型和遗传重叠而复杂;纳入独有基因可能提高诊断率,但这些基因研究较少,其在CASA发病中的作用不确定;严谨的前瞻性诊断率研究将有助于选择检测组合。
研究设计与样本
- 观察性研究,从5家商业实验室收集公开可得的NGS-MGP信息,比较白内障、青光眼、ASD、MAC、角膜营养不良和ARS的组合基因组成、共识率、独有率和内含子变异覆盖,并比较单个基因的发表历史及与系统性疾病关联。
主要发现
- 白内障、青光眼、角膜营养不良、MAC、ASD和ARS组合分别检测239、60、36、292和10个离散基因。
- 共识率介于16%和50%之间,独有率介于14%和74%之间。
- 汇总所有疾病的并发基因后,20%的基因在2种或以上疾病中为并发基因。
- 白内障和青光眼中,并发基因与疾病的相关性均显著强于独有基因。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出这些独有基因研究较少,其在CASA发病中的作用不确定。
- 作者指出需要严谨的前瞻性诊断率研究来帮助做出CASA诊断中组合选择的决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We compared next generation sequencing multigene panels (NGS-MGP) from 5 commercial laboratories to inform ophthalmologists' decision making in diagnostic genetic testing for congenital anterior segment anomalies (CASAs). DESIGN: Comparison of commercial genetic testing panels. METHODS: This observational study gathered publicly available information on NGS-MGP from 5 commercial laboratories for the following: cataracts, glaucoma, anterior segment dysgenesis (ASD), microphthalmia-anophthalmia-coloboma (MAC), corneal dystrophies, and Axenfeld-Rieger syndrome (ARS). We compared gene panel composition, consensus rate (genes covered by all the panels per condition, "concurrent"), dissensus rate (genes covered by only 1 panel per condition, "standalone"), and intronic variant coverage. For individual genes, we compared publication history and association with systemic conditions. RESULTS: Altogether, cataract, glaucoma, corneal dystrophies, MAC, ASD, and ARS panels tested 239, 60, 36, 292, and 10 discrete genes, respectively. The consensus rate varied between 16% and 50%, and the dissensus rate varied between 14% and 74%. After pooling concurrent genes from all conditions, 20% of these genes were concurrent in 2 or more conditions. For both cataract and glaucoma, concurrent genes had significantly stronger correlation with the condition than standalone genes. CONCLUSIONS: The genetic testing of CASAs using NGS-MGPs is complicated, owing to their number, variety, and phenotypic and genetic overlap. Although the inclusion of additional genes, such as the standalone ones, might increase diagnostic yield, these genes are also less well studied, indicating uncertainty over their role in CASA pathogenesis. Rigorous prospective diagnostic yield studies of NGS-MGPs will aid in making decisions of panel selection for the diagnosis of CASAs.
引用
- Villalba MF, Li CM, Pakravan P, et al. Commercial Gene Panels for Congenital Anterior Segment Anomalies: Are They All the Same? Am J Ophthalmol. 2023. PMID: 36906093. doi:10.1016/j.ajo.2023.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。